RecruitingNCT05001477

Customized TULSA-PRO Ablation Registry

Sponsor

Profound Medical Inc.

Enrollment

1,000 participants

Start Date

Oct 27, 2021

Study Type

OBSERVATIONAL

Conditions

Prostate Cancer Prostate Adenocarcinoma Benign Prostatic Hyperplasia

Summary

This patient registry will capture data from patients who have been or who are undergoing the transurethral ultrasound ablation (TULSA) procedure as part of their routine clinical care. The registry will shed light on real-world outcomes of safety and efficacy of the procedure and understand how a patient's quality of life is affected throughout their follow-up and lifetime.

Eligibility

Sex: MALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This registry study tracks real-world outcomes for men who receive a treatment called TULSA-PRO, a focused ultrasound procedure used to destroy prostate tissue and treat prostate cancer or benign prostate conditions with minimal side effects. **You may be eligible if...** - You are male and 18 or older - You are a candidate for and planning to undergo TULSA-PRO treatment - You are willing to sign an informed consent form **You may NOT be eligible if...** - You are not scheduled to receive TULSA-PRO treatment - There are no other specific exclusion criteria listed Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.